EN | RU
EN | RU

Help Support

Back

Efficacy of Levonorgestrel-releasing intrauterine system as postoperative maintenance therapy of endometriosis

Efficacy of Levonorgestrel-releasing intrauterine system as postoperative maintenance therapy of endometriosis Efficacy of Levonorgestrel-releasing intrauterine system as postoperative maintenance therapy of endometriosis
Efficacy of Levonorgestrel-releasing intrauterine system as postoperative maintenance therapy of endometriosis Efficacy of Levonorgestrel-releasing intrauterine system as postoperative maintenance therapy of endometriosis

To compare the efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) with other treatments as postoperative maintenance therapy for endometriosis concerning pain reduction, recurrence prevention, side effects and patients’ satisfaction.

See All

Key take away

This analysis portrayed that the levonorgestrel-releasing intrauterine system (LNG-IUS) provides higher satisfaction rate of patients without systemic adverse drug reaction than other treatments and significantly prevents the recurrence of dysmenorrhea. Hence, LNG-IUS might be a treatment option as maintenance therapy after the surgical management for endometriosis.

Background

To compare the efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) with other treatments as postoperative maintenance therapy for endometriosis concerning pain reduction, recurrence prevention, side effects and patients’ satisfaction.

Method

The investigators searched MEDLINE, EMBASE, and the Cochrane Library from January 1986 to February 2018. Two evaluators independently extracted and reviewed the prospective and retrospective articles as per the predetermined selection criteria. Outcomes were determined as mean difference (MD), risk ratios (RR) or odds ratios (OR) in a meta-analysis model, using the Revman software.

Result

From a total of 962 studies, 7 studies were selected. These 7 studies comprised of four randomized controlled trials with 212 patients, one prospective cohort study with 88 patients, and two retrospective studies with 191 patients. According to the meta-analysis, LNG-IUS  significantly reduced the pain after surgery (MD = 12.97, 95% CI: 5.55–20.39), with a comparable effect to gonadotropin-releasing hormone analogues (MD = −0.16, 95% CI: −2.02 to 1.70). LNG-IUS was also effective in reducing the recurrence rate (RR = 0.40, 95% CI: 0.26–0.64), with an effect comparable to OC (OR = 1.00, 95% CI: 0.25–4.02) and danazol (RR = 0.30, 95% CI: 0.03–2.81). Also, patients' satisfaction with LNG-IUS was significantly higher than that with OC (OR = 8.60, 95% CI: 1.03–71.86). Vaginal bleeding was significantly higher in the LNG-IUS group as compared to the gonadotropin-releasing hormone analogue group (RR = 27.0, 95% CI: 1.71–425.36).

Conclusion

This meta-analysis portrayed a positive effect of LNG-IUS as postoperative maintenance therapy for endometriosis on pain relief, prevention of dysmenorrhea recurrence, and the patient's satisfaction.

Source:

European Journal of Obstetrics and Gynecology

Article:

Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis

Authors:

Soo Youn Song et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: